Sweden· SE-20110610000032
Zoledronic Acid Hospira 4 mg/100 ml Infusionsvätska, lösning
A medicinal product containing zoledronic acid, registered in Sweden by Pfizer Europe MA EEIG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Zoledronic Acid
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- August 27, 2026
Packs & prices · 1
- se_varunummer20110610000032
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zoledronic acid in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumZoledronate EG 4 mg/100 mlEG
- FinlandTsoledronihappo MedacMedac Gesellschaft Für Klinische Spezialpräparate mbH
- SpainACIDO ZOLEDRONICO ACCORD 4 MG/100 ML SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- PolandOsporilEGIS Pharmaceuticals PLC
- United Stateszoledronic acidSagent Pharmaceuticals
- IcelandAszoraanwerina Deutschland GmbH
- NorwayZoledoAccord Healthcare B.V.
- IrelandZerlinda 4 mg/100 ml solution for infusionTeva B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Zoledronic Acid Koanaa, Zoledronsäure Fresenius Kabi
- Belgium · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
- Bulgaria · Золедронова Киселина Ейсфарма, Золедронова Киселина Ромфарм
- Cyprus · Nordeloz, Zoledronic Acid Altan
- Czechia · Zoledronic Acid Fresenius Kabi, Zomikos
- Germany · Aszora, Clastizol
- Denmark · Zoledo, Zoledronsyre Fresenius Kabi
- Estonia · Zoledronic Acid Fresenius Kabi
- Spain · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
- Finland · Zobiore, Zoledronic Acid Fresenius Kabi
- France · Acide Zoledronique Altan, Acide Zoledronique Biogaran
- United Kingdom (Northern Ireland) · Zerlinda, Zoledronic Acid
- Greece · Bonevin, Nordeloz
- Croatia · Zolenat
- Hungary · Osporil, Zoledronsav Fresenius Kabi
- Ireland · Zerlinda, Zoledronic Acid
- Iceland · Aclasta, Aszora
- Italy · Acido Zoledronico Altan, Acido Zoledronico Fresenius Kabi
- Liechtenstein · Aclasta, Zoledronic Acid Accord
- Lithuania · Zoledronic Acid Fresenius Kabi
- Luxembourg · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
- Latvia · Zoledronic Acid Fresenius Kabi
- Netherlands · Zoledroninezuur Accord, Zoledroninezuur Cf
- Norway · Aclasta, Zoledo
- Poland · Osporil, Zerlinda
- Portugal · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
- Romania · Acid Zoledronic Accord, Acid Zoledronic Fresenius Kabi
- Slovenia · Zoledronska Kislina Accord, Zoledronska Kislina Fresenius Kabi
- Slovakia · Kyselina, Kyselina Zoledrónová Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be1c2465-0517-4510-9f8d-da7328936857 GET /v1/drugs/be1c2465-0517-4510-9f8d-da7328936857?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20110610000032",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20110610000032",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/zoledronic-acid-hospira"
}See everything about zoledronic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.